SaraRTabtabaiMDFACC

Cardiology • Hartford, CT

Heart Failure & Transplantation

Advanced Heart Failure and Transplant Cardiologist

Join to view full profile

Dr. Tabtabai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tabtabai's full profile

Already have an account?

Office
St. Francis Hospital & Medical Center
114 Woodland St
Hartford, CT 06105

Education & Training

Massachusetts General HospitalFellowship, Cardiovascular Disease, 2012 - 2015
Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
Uconn School Of MedicineClass of 2009

Certifications & Licensure

CT State Medical License 2016 - 2025
MA State Medical License 2012 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Cardiovascular Care in the United States: Penny Wise and Pound Foolish.
Tariq Ahmad, Nihar R Desai, Sara Tabtabai
Journal of the American College of Cardiology. 2024-08-20
1 citations
Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities.
Min-Jung Kim, Robert H Aseltine Jr, Sara R Tabtabai
The American Journal of Cardiology. 2024-01-01
1 citations
Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis.
Min-Jung Kim, Sara R Tabtabai, Robert H Aseltine Jr
The American Journal of Cardiology. 2023-11-15

Journal Articles

Sick Sinus Syndrome in Cardiac Noncompaction
Sara Tabtabai, Joyce Meng, oncology-and-radiotherapy.com.marlin-prod.literatumonline.com

Press Mentions

Only Small Minority of Eligible Patients Prescribed SGLT2 InhibitorsAugust 15th, 2024